Estrogen has wide-ranging and complex effects on the reproductive axis, which are often difficult to interpret from in vivo studies. Estrogen negatively regulates tonic GnRH synthesis and also plays a pivotal role in the positive regulation of GnRH necessary for the preovulatory surge. To dissect the mechanisms by which these divergent effects occur, we attempted to observe the direct action of estrogen on the regulation of GnRH messenger RNA (mRNA) levels using the well characterized, GnRH-secreting, hypothalamic cell line, GT1-7. Using RT-PCR, we first investigated estrogen receptor transcript expression in GT1-7 neurons. We found that the GT1-7 cells express both estrogen receptor-␣ (ER␣) and the recently described ER␤ mRNAs. We also detected the presence of both receptor subtypes in the GT1-7 neurons by Western blot analysis using specific ER antibodies. By Northern blot analysis of total GT1-7 RNA, we found that 17␤-estradiol (1 nM) down-regulates GnRH mRNA levels to approximately 55% of basal levels over a 48-h time course. This effect appears to occur specifically through an ER-mediated mechanism, as ICI 182,780, a complete ER antagonist, blocks the repression of GnRH mRNA levels by estradiol. The recently reported ER␣-specific agonist/ ER␤-specific antagonist 2,2-bis-(p-hydroxyphenyl-1,1,1-trichloroethane (HPTE), a methoxychlor metabolite, also down-regulated GnRH gene expression. The repression of GnRH mRNA levels appears to occur at the transcriptional level, as simian virus 40 T antigen mRNA expression, which is under the control of 2.3 kb of the rat GnRH 5Ј-regulatory region, mimics the down-regulation of GnRH after treatment with estradiol. As the rat GnRH regulatory region in GT1-7 neurons does not appear to harbor a classic estrogen response element, the mechanism involved in the repression of GnRH has yet to be determined. These results suggest that estradiol directly regulates GnRH gene expression at the level of the GnRH neuron and may exert its neuroendocrine control through direct interaction with specific receptors expressed in these cells. (Endocrinology 140: [5045][5046][5047][5048][5049][5050][5051][5052][5053] 1999) 
appears to occur specifically through an ER-mediated mechanism, as ICI 182,780, a complete ER antagonist, blocks the repression of GnRH mRNA levels by estradiol. The recently reported ER␣-specific agonist/ ER␤-specific antagonist 2,2-bis-(p-hydroxyphenyl-1,1,1-trichloroethane (HPTE), a methoxychlor metabolite, also down-regulated GnRH gene expression. The repression of GnRH mRNA levels appears to occur at the transcriptional level, as simian virus 40 T antigen mRNA expression, which is under the control of 2.3 kb of the rat GnRH 5Ј-regulatory region, mimics the down-regulation of GnRH after treatment with estradiol. As the rat GnRH regulatory region in GT1-7 neurons does not appear to harbor a classic estrogen response element, the mechanism involved in the repression of GnRH has yet to be determined. These results suggest that estradiol directly regulates GnRH gene expression at the level of the GnRH neuron and may exert its neuroendocrine control through direct interaction with specific receptors expressed in these cells. (Endocrinology 140: [5045] [5046] [5047] [5048] [5049] [5050] [5051] [5052] [5053] 1999) E STROGEN is a critical gonadal steroid hormone involved in reproductive physiology. Estrogen negatively regulates tonic GnRH synthesis, but it is also necessary to induce the preovulatory surge of GnRH. A large number of studies have demonstrated the pivotal role that estrogen plays in the negative feedback control of the hypothalamicpituitary-gonadal axis to control the intricate balance of hormone levels necessary to maintain reproductive function (1, 2) . Several studies carried out in vivo have demonstrated estrogen-mediated suppression of GnRH secretion through either direct or indirect mechanisms. In contrast, stimulation of GnRH secretion necessary for the preovulatory surge has been linked to the activation of at least five afferent neurotransmitter pathways (reviewed in Ref. 2) .
Due to the dramatically divergent results observed, it is still controversial whether estrogen modulates GnRH transcription in vivo (2) . Conflicting results have been obtained depending on the time the rats were killed, the location of the GnRH neuron within the medial septal-preoptic hypothalamic regions, the length of time after castration, and the dose and time of estrogen treatment (3) . It has been postulated that stimulation of GnRH gene expression occurs via the same neurotransmitter pathways found to be responsible for the enhancement of GnRH secretion (3) . On the other hand, there is almost no information available regarding the mechanisms of negative regulation of GnRH gene expression by estrogen.
Estrogen may influence the GnRH neuron directly, but currently there is little evidence for the expression of estrogen receptors (ERs) in native GnRH neurons. In the early 1980s, the estrogen responsiveness of the GnRH neuron was established electrophysiologically by Kelley et al. (4) , who demonstrated that estrogen inhibits the firing of GnRH neurons in hypothalamic slices obtained from female guinea pigs. At almost that same time, however, Shivers et al. reported that GnRH neurons do not concentrate estradiol (5). This study was followed by a number of reports using immunocytochemistry performed in rats (6) , guinea pigs (7), sheep (8) , and monkeys (9), in which none or only a few rare GnRH-immunoreactive hypothalamic neurons colocalized with ER expression, which led to the present belief that GnRH neurons could not be directly affected by estrogen. Instead, estrogen-receptive interneurons contacting GnRH neurons are thought to be responsible for mediating the effects of estrogen and other sex steroids on GnRH synthesis and secretion (5, 10, 11) .
The scarcity of GnRH neurosecretory neurons makes study of their cell and molecular biology difficult. Classical in vivo approaches cannot establish the direct action of agents such as gonadal steroids on the GnRH neuron or on GnRH transcription, mainly because the GnRH system receives input from other steroid-sensitive cells. In an attempt to produce a suitable model to study the GnRH gene, a targeted tumorigenesis technique was used to develop a murine immortal cell line of GnRH-secreting hypothalamic neurons (GT1 cells) (12) . To date, the GT1 cells have proven to be the best characterized cell model available to study biology of the hypothalamic GnRH neurons (13, 14) .
The development of the GT1 cell line has allowed study of the direct actions of sex steroids on GnRH neurons. Glucocorticoid receptor-mediated repression of GnRH promoter activity has been demonstrated in GT1 cells (15) . Poletti et al. reported that GT1 neurons also bind androgens and metabolize this gonadal steroid via the two major enzymatic pathways involved in the modulation of androgen action (16, 17) . In agreement with these initial studies, our laboratory has demonstrated the expression of a functional androgen receptor in the GT1 cells and down-regulation of GnRH messenger RNA (mRNA) levels after 5␣-dihydrotestosterone treatment (18) . In addition to androgen-binding activity, Poletti et al. detected the presence of specific binding sites for estrogen in GT1 cells (16) . Another recent study has demonstrated that these cells express ER␣ mRNA and exhibit specific estrogen-binding activity, and through transient transfection analysis found that the ER expressed in the GT1 cells can activate an exogenous estrogen-responsive element (ERE)-luciferase plasmid (19) . These findings strengthened the hypothesis that estrogen may directly regulate gene expression in the GnRH neuron.
To determine whether regulation of gene expression by estrogen contributes to its negative feedback action on GnRH neurons, we studied the direct effect of estrogen on GnRH mRNA levels in GT1-7 neurons. We report both ER␣ and ER␤ mRNA and protein expression in GT1-7 GnRH-secreting neurons. We also demonstrate that 17␤-estradiol as well as 2,2-bis-(p-hydroxyphenyl-1,1,1-trichloroethane (HPTE), an ER␣ agonist, down-regulate GnRH mRNA levels in GT1 cells through an ER-specific mechanism. Interestingly, the down-regulatory effect appears to be mediated at the transcriptional level. These observations provide evidence that the estrogen-mediated inhibition of GnRH gene expression is exerted via ERs in the GT1-7 cells, the current model system of the hypothalamic GnRH neuron.
Materials and Methods

Cell culture and reagents
GT1-7 cells were grown in monolayer in DMEM (Life Technologies, Inc., Burlington, Canada) supplemented with 10% FBS (HyClone Laboratories, Inc., Logan, UT), 4.5 mg/ml glucose, and penicillin/streptomycin and maintained at 37 C in an atmosphere of 5% CO 2 as previously described (12) . Cells were maintained in phenol red-free DMEM supplemented with 10% charcoal-stripped FBS, prepared as previously described (20) 
Northern blot analysis
Northern blot analysis was performed as previously described (21) . Briefly, total cellular RNA was isolated by the guanidinium thiocyanate phenol chloroform extraction method (22) . Ten micrograms of total RNA were size fractionated in 1% agarose-formaldehyde gels and transferred to GeneScreen membranes (NEN Life Science Products, Boston, MA) by capillary blotting (23) . The filters were hybridized with rat GnRH complementary DNA (cDNA) (24) or simian virus 40 (SV40) T antigen (TAg) cDNA (25) . Hybridization with mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA generated by RT-PCR or human ␥-actin cDNA (26) was used to control for variations in gel loading and transfer efficiency. GnRH and ␥-actin probes were routinely hybridized concurrently to minimize error caused by stripping and reprobing of the membrane. Prehybridization for 2-16 h and hybridization for 16 h were conducted in a 25% formamide hybridization buffer [1% wt/vol BSA, 1 mm EDTA, 0.5 m Na 2 HPO 4 , 5% (wt/vol) SDS, and 25% formamide] at 55 C. The cDNA probes were labeled using random hexamers and [ 32 P]deoxy-ATP (6000 Ci/mmol; NEN Life Science Products) incorporated with the Klenow fragment of DNA polymerase I (27) . Blots were washed at high stringency (55 C; 0.5 ϫ SSC, 0.1% SDS) and exposed to Fuji film (obtained from Fisher Scientific Ltd., Nepean, Ontario, Canada) at Ϫ70 C with intensifying screens for 4 -48 h. Autoradiographs were scanned with a Hewlett-Packard Co. ScanJet 3p Scanner (Palo Alto, CA), and GnRH, TAg, actin, and GAPDH mRNA signals were quantified by densitometry using the NIH Image program. Statistical significance of the results was determined by Student's t test, as indicated.
RT-PCR and DNA sequencing
Total RNA was isolated from GT1-7 cells and from mouse ovary, cerebellum, and testes, as described above. First strand cDNA was synthesized from 1-10 g deoxyribonuclease I-treated RNA, using SuperScript II reverse transcriptase (RT) and oligo(deoxythymidine), as described in the Superscript II cDNA Synthesis Kit (Life Technologies, Inc.). The specificity of each amplification reaction was monitored in control reactions, where amplification was carried out on samples in which the RT was omitted. Amplification of H3 histone cDNA (222 bp) was used as a control to determine first strand cDNA quality.
PCR amplifications were performed with 1.25 U Taq polymerase (Life Technologies, Inc.) in a 50-l reaction for 35 cycles (1.5 min at 94 C, 1.5 min at 57 C for ER␣ and 65 C for ER␤, and 1.5 min at 72 C). Primers were designed from the mouse ER sequences in GenBank to span introns. External and internal primers were used to amplify ER␣ cDNA. A PCR product of the expected size (344 bp) was amplified with the external primers 5Ј-GAATTCAATTCTGACAATCGACGCCAG-3Ј and 5Ј-GAATTCGTGCTTCAACATTCTCCCTCC-3Ј. This external PCR product was used as a template for a second PCR using the internal primers 5Ј-GAATTCGAGAAAGGAAACATGATCATG-3Ј and GAATTCT-TCATCATGCCCACTTCGTAA-3Ј to amplify a product of 247 bp. ER␤ cDNA was amplified using external primers for ER␤ (5Ј-GAAT-TCTAGCCACCCACTGCCAATCAT-3Ј and 5Ј-GAATTCCACACCTT-TCTCTCCTGGATC-3Ј; expected size, 407 bp). These products were separated by 1.8% agarose gel electrophoresis, Southern transferred onto GeneScreen hybridization membrane (NEN Life Science Products) by capillary blotting (23) , and hybridized with an internal ER␤ cDNA probe, using the hybridization and washing conditions described above. The internal ER␤ probe was generated from mouse ovarian cDNA using primers 5Ј-GAATTCCAGAACCTCAAAAGAGTCCTT-3Ј and 5Ј-GAATTCCGTAACACTTGCGAAGTCGGC-3Ј, and its identity was confirmed by sequencing. Primers used to amplify the rat GAPDH cDNA were sense 5Ј-TCCACCACCCTGTTGCTGTAG-3Ј and antisense 5Ј-GACCACAGTCCATGACATCACT-3Ј. All primers were made by ACGT Corp. (Toronto, Canada).
ER␣ and ER␤ PCR products from the GT1-7 cells were electrophoresed in 1.8% agarose gels, stained with 1 g/ml ethidium bromide, and visualized under UV light. Corresponding DNA fragments were isolated and purified using GeneClean (BIO 101, Inc., Vista, CA) and subcloned into pCR2.1-TOPO cloning vector using the TOPO TA Cloning Kit (Invitrogen, Carlsbad, CA). DNA was prepared for sequencing using the Wizard Plus Miniprep Kit (Promega Corp., Madison, WI) according to the manufacturer's instructions. DNA sequencing was performed by the dideoxy-sequencing method of Sanger et al. (28) using the T7 Sequencing Kit (Pharmacia Biotech, Piscataway, NJ) and [ 35 S]deoxy-ATP (10 mCi/ml; Amersham Pharmacia Biotech, Arlington Heights, IL). Sequencing reactions were run on 6% polyacrylamide gels for 3-6 h. Gels were then dried and exposed to Kodak X-600 autoradiography film (Eastman Kodak Co., Rochester, NY) for 16 h. Sequences were confirmed using the NIH Blast Program.
Immunoprecipitation and Western blot analysis
Confluent GT1-7 cells were washed twice with ice-cold PBS containing protease inhibitors leupeptin (10 g/ml), aprotinin (10 g/ml), and PMSF (1 mm) and lysed with Nonidet P-40 lysis buffer [50 mm HEPES (pH 7.25), 150 mm NaCl, 0.1 mm ZnCl 2 , 2 mm EDTA, 1% (vol/vol) Nonidet P-40, and 2 mm PMSF]. Mouse ovary, testes, cerebellum, or hypothalami (controls) were homogenized in Nonidet P-40 lysis buffer. Cell debris was removed by centrifugation at 12,000 rpm for 10 min at 4 C, and the supernatants were used for immunoprecipitation and/or Western blotting analysis. For the ER␤ immunoprecipitation, the clarified supernatant was incubated with 4% (vol/vol) Protein G-Plus agarose (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) for 1 h at 4 C, then centrifuged at 12,000 rpm for 10 min to remove the agarose beads. ER␤ was immunoprecipitated from the precleared supernatant by the addition of 1 g/ml polyclonal rabbit antirat ER␤ antisera and 4% (vol/vol) Protein G-Plus agarose overnight with agitation at 4 C. Samples were centrifuged at 12,000 rpm for 10 min at 4 C, and the pellets were washed four times with Nonidet P-40 lysis buffer. Crude protein extracts (for ER␣) or immunoprecipitated proteins (for ER␤; 50 g of each) were suspended in Laemmli sample buffer to a final concentration of 1 ϫ and boiled for 5 min before resolution on a 10% SDS-PAGE gel. Proteins were transferred to an Immobilon polyvinylidene difluoride membrane (Millipore Corp., Bedford, MA). The membranes were incubated in TBST blocking solution [50 mm Tris-HCl (pH 7.4), 0.15 m NaCl, 0.2% (vol/vol) Tween-20, and 5% powdered skim milk] for 24 h with 1 g/ml of either polyclonal rabbit antimouse ER␣ or antirat ER␤ antisera [ER␣, MC-20 (directed toward the carboxyl-terminal of the mouse ER␣; sc-542, Santa Cruz Biotechnology, Inc.); ER␤, PA1-310 (Affinity BioReagents, Inc., Golden, CO)]. For peptide blocking analysis, the ER␣ or ER␤ immunizing peptide [5 g/ml; MC-20 blocking peptide (Santa Cruz Biotechnology, Inc.) or PA1.1-310 (Affinity BioReagents, Inc.), respectively] was preincubated with their respective antibodies for 1 h at room temperature before immunoprecipitation and/or Western blot analysis. Immunoreactive bands were visualized with horseradish peroxidaselabeled secondary goat antirabbit antiserum at a 1:5000 dilution and enhanced chemiluminescence (ECL Kit, Amersham Pharmacia Biotech, Inc., Oakville, Canada) as described by the manufacturer.
Results
ER expression in GT1-7 cells
Estrogen is known to have a profound effect on the regulation of reproductive function through the GnRH neuron; however, it is not yet known whether the GnRH neuron itself contains receptors for estrogen. Previous studies have indicated that the GT1 cells contain ER-binding activity (16, 19) and the mRNA for ER␣ (19) . We have used RT-PCR to test for the presence of cDNAs from both ER␣ and ER␤ in GT1-7 cells. Our results confirm that ER␣ is expressed in GT1-7 cells, but, additionally, ER␤ transcripts are present in these cells (Fig. 1, A and 1B) . Mouse ovary cDNA was amplified using the ER primers and served as a positive control for both ER mRNAs. DNA sequencing of the cloned PCR products confirmed their identity with the mouse ER sequences. The ER␤ cDNA was consistently difficult to amplify by PCR in both GT1 cells and mouse ovary, suggesting either low expression levels or an inherently unstable ER␤ mRNA.
To verify that the ER mRNAs are translated and also to confirm our RT-PCR results, we performed Western blot analysis to detect the presence of both ER proteins in the GT1-7 neurons. The anti-ER␣ antiserum recognizes an immunoreactive band at 67 kDa in GT1-7 cells (Fig. 2A) , which comigrates with a protein of identical mobility highly expressed in mouse ovary and to a lower level in mouse testes, as expected from analysis of ER␣ transcript distribution in the rat (29) . This protein is not expressed in mouse cerebellum, which, in the rat, was previously found to express mainly ER␤ (29) . Although we have tried a number of commercially available anti-ER␣ antiserum, none was able to detect only a single band at 67 kDa, the predicted molecular mass of ER␣, in the GT1-7 cells or the other tissues tested. We often found a few smaller immunoreactive bands on the Western blots. Interestingly, all of them were specifically competed by the ER␣ peptide, suggesting that the smaller   FIG. 1 . Identification of transcripts for ER␣ and ER␤ in GT1-7 neurons. cDNA was synthesized with (ϩ) or without (Ϫ) RT from total RNA isolated from GT1-7 cells and mouse ovary (positive control). The cDNA was used as a template for PCR with primers specifically designed to amplify either ER␣ [A; with external (E) or internal (I) primers] or ER␤ (B). A, PCR products were size fractionated by agarose gel electrophoresis and visualized by ethidium bromide staining. Amplification of histone H3 (H3) transcripts was used to control for the integrity of the RNA in the RT-PCR. B, PCR products were size fractionated by agarose gel electrophoresis, Southern transferred onto GeneScreen hybridization membrane, and hybridized with an internal ER␤ cDNA probe from mouse ovary. Molecular mass marker sizes are indicated (M). PCR products from GT1-7 cells of both ER␣ and ER␤ were sequenced to verify identity.
bands are probably degradation products or alternatively truncated ER␣ products.
Using a specific antibody to ER␤, we found two specific complexes, of 55 and 80 kDa after immunoprecipitation and Western blot analysis in GT1-7 cells (Fig. 2B) . These complexes were also present in mouse ovary and hypothalamus, as expected from the analysis of transcript distribution of ER␤ in the rat (29) . The 55-kDa band, which corresponds to the predicted molecular mass, was specifically competed by the immunizing peptide. Interestingly, the closely migrating bands at approximately 80 kDa were also competed, although to a lesser degree, by the ER␤ peptide. We presently have no explanation for the larger band, but it may simply represent a nonspecific reaction to the antiserum. Our results confirm the previous study, indicating the presence of ER␣ in the GT1 cells, but to our knowledge, this is the first report indicating ER␤ expression, at both mRNA and protein levels, in GT1-7 neurons.
Effect of 17␤-estradiol on GnRH mRNA levels
To understand the potential role of ERs in the GnRH neuron, we looked for a direct effect of estrogen on these cells. The GT1 cells are the optimal system to study the direct effects of estrogen on GnRH gene expression due to the homogeneity of the cell population. These studies are a difficult, if not a technically impractical, task in vivo. We used the GT1-7 cells exposed to 17␤-estradiol over a 48-h time course to study the effect of estrogen on GnRH mRNA synthesis. Repression of GnRH mRNA levels was statistically significant (P Ͻ 0.005) over a 48-h time course upon treatment with 1 nm 17␤-estradiol (Fig. 3, A and B) . The medium
FIG. 2. Detection of both ER␣ and ER␤
protein in GT1-7 cells. Cell lysates from GT1-7 neurons and protein extracts from mouse ovary, testes, cerebellum, and hypothalamus (controls) were isolated and subjected to SDS-PAGE. Western blot analysis was performed with enhanced chemiluminescence using specific antibodies for ER␣ (A) and ER␤ (B; with immunoprecipitation before SDS-PAGE). The specificity of the immunoreactive bands was determined in parallel blots incubated with the antibody in conjunction with the peptide used to create the antibody (ϩ peptide panels). The 50-kDa band in B corresponds to the IgG heavy chain.
was devoid of phenol red, which was previously shown to exhibit estrogenic effects on the proliferation of MCF-7 human breast cancer cells (30), although we found that there was little if any difference in the level of repression using either phenol red-devoid medium or medium with phenol red. Vehicle alone (14 nm dimethylsulfoxide) did not change GnRH mRNA levels over time, although there was a negligible increase (not statistically significant) in GnRH mRNA levels compared with that in nonvehicle controls (data not shown). When the initial studies were conducted, we used ␥-actin as a loading control. Actin has been shown to be regulated by estradiol during mitogenic stimulation of rat uterine cells (31) ; therefore, we also probed these same blots with mouse GAPDH and 18S cDNAs. All three probes exhibited a similar hybridization pattern, indicating that in the GT1-7 cells, ␥-actin gene expression is not regulated by estradiol over a 48-h time course, suggesting that it is an appropriate loading control.
Effects of ER agonist/antagonist in GT1-7 neurons
A complete ER antagonist, ICI 182,780, was used to determine whether the down-regulation of GnRH mRNA levels was specifically due to an ER-mediated mechanism. Addition of ICI 182,780 to GT1-7 cells together with estradiol at two relevant time points (24 and 36 h) blocked the repression of GnRH gene expression by estradiol (Fig. 4A) . ICI 182,780 alone did not significantly change steady state GnRH mRNA levels. This indicates that repression of GnRH mRNA levels by estradiol is an ER-mediated effect, but as ICI 182,780 antagonizes both ER␣ and ER␤ activities, we cannot yet determine which ER is involved in this process.
A number of environmental compounds have been shown to exhibit estrogenic activity. Recently, HPTE, an estrogenic metabolite of methoxychlor, an organochlorine pesticide, has been found to exhibit differential ER agonist/antagonist properties for the two ERs. HPTE appears to be an agonist for ER␣ and an antagonist for ER␤ in a number of different cell lines, including HepG2 cells, and on numerous estrogensensitive exogenous promoters (32) . We treated the GT1-7 neurons with HPTE to decipher which ER may be responsible for the down-regulation of GnRH mRNA levels by estradiol. At 24 and 36 h, 100 nm HPTE mimics the effects of estradiol in GT1-7 cell culture experiments. HPTE, either alone or in combination with estradiol, down-regulates GnRH mRNA levels to approximately 50% of basal GnRH mRNA levels (Fig. 4B) . These results indicate that ER␣ is involved in the regulation of GnRH synthesis by estradiol, but we cannot yet determine whether the two ERs form a heterodimer complex to achieve the repression of GnRH mRNA levels. It has been shown that hydroxytamoxifen (OHT), an antagonist of ER, exhibits differential binding activity to either ER isoforms, with an apparent shift in the dose response toward the lower concentrations for ER␤ compared with ER␣ (33) . Using this information, we treated the GT1-7 cells with OHT to distinguish ER isoform activities at different concentrations. Unfortunately, in our hands, OHT at concentrations between 10 Ϫ9 -10 Ϫ7 m appears to exhibit agonist activity, similar to that of estradiol, in GT1-7 cells and therefore could not be used in these studies. Until a more useful agent is described to distinguish between the activities of the two ER isoforms, we can report only that ER␣ is necessary for the repression of GnRH mRNA levels. We continue to look for evidence that ER␤ is also involved in this process in the GnRH-secreting GT1-7 cell line.
Transcriptional regulation of GnRH mRNA levels by 17␤-estradiol
The down-regulation of GnRH synthesis by estradiol in the GT1-7 neurons may be achieved either at the transcriptional level or by changes in RNA stability. To understand how estradiol down-regulates GnRH steady state mRNA levels, we studied changes in the mRNA levels of the exogenous oncogene expressed in the immortalized GT1-7 cell line. The GT1 cells were produced using the potent oncogene, TAg, under the control of 2.3 kb of the rat GnRH 5Ј-regulatory region. There is no endogenous expression of this protein in these cells. Two TAg transcripts are produced through alternative splicing at 2450 and 2200 bp, although FIG. 3 . Effect of estradiol on steady state GnRH mRNA levels in GT1-7 neurons. GT1-7 cells were treated with 1 nM 17␤-estradiol or vehicle alone over a 48-h time course. At the indicated time points, total RNA was extracted, and 10 g of each sample were subjected to Northern blot analysis. Blots were probed simultaneously with rat GnRH cDNA and human ␥-actin cDNA. GnRH mRNA levels were quantified by scanning densitometry of autoradiographs and normalized to the loading control (␥-actin). A, The data shown are relative GnRH mRNA levels and are expressed as the mean Ϯ SEM (n ϭ 9 independent experiments). **, P Ͻ 0.005 vs. corresponding vehicle controls. B, Representative Northern blot corresponding to the data shown in A.
the expression of the larger transcript is low in GT1-7 cells (12) . We have used TAg cDNA to probe the same Northern blots used to detect the down-regulation of GnRH mRNA by estradiol. TAg mRNA expression mimics that of GnRH (Fig.  5) . This indicates that the region responsive to estrogen, probably through an ER homo-or heterodimer, lies within the same region used to create the cell line. This region encompasses DNA from Ϫ2987 to Ϫ1172 and from Ϫ441 to ϩ104 of the rat GnRH 5Ј-regulatory region (12) . Although this region does not appear to contain a classic ERE, it is possible that the down-regulatory effect mediated by estrogen at the transcriptional level uses a unique ERE sequence.
FIG. 4. ER antagonist and agonist activity in GT1-7 neurons. GT1-7 cells
were treated with A) ICI 182,780 (ICI) with or without 1 nM 17␤-estradiol (E) or vehicle alone or B) HPTE with or without 1 nM 17␤-estradiol or vehicle alone for 24 and 36 h. At the indicated time points, total RNA was extracted, and 10 g of each sample were subjected to Northern blot analysis. Blots were probed simultaneously with rat GnRH cDNA and human ␥-actin cDNA. GnRH mRNA levels were quantified by scanning densitometry of autoradiographs and normalized to the loading control (␥-actin). The data shown are relative GnRH mRNA levels and are expressed as the mean Ϯ SEM [n ϭ 3 (ICI, ICIϩE, HPTE, and HPTEϩE) or n ϭ 9 (E) independent experiments]. **, P Ͻ 0.005 as indicated (A) or vs. corresponding vehicle controls (B).
Discussion
Although it is known that estrogen exerts important physiological regulation of the hypothalamic-pituitary-gonadal axis, the mechanism(s) through which this gonadal steroid mediates control of GnRH neurons in the hypothalamus is not clearly understood. Because the GnRH neuron itself was not thought to contain ERs, it was believed that indirect control by estrogen-responsive neuronal systems contacting the GnRH neuron was responsible for mediating the effects of estrogen and other sex steroids on GnRH synthesis and secretion.
Renewed interest in the mechanism of estrogen action on the GnRH neuron has been generated by a few studies using the model GT1 cell line, which have provided new evidence suggesting that functional ERs may be expressed in the hypothalamic GnRH neuron. These studies have indicated that the GnRH-secreting GT1 neuronal cell line contains high affinity binding sites for estrogens (16) , although as might have been anticipated from previous in vivo studies of GnRH neurons, the number of estradiol-binding sites found in GT1 cells appears to be low (16, 19) . Using sensitive RT-PCR, we have found that both ER␣ and ER␤ mRNAs are expressed in the GT1-7 cells. These findings confirm the results from previous studies that indicated the presence of ER␣ transcripts in GT1 cells (19) and from a preliminary study that indicated the expression of both ERs (34) . We also confirmed that the ER mRNAs are translated into their respective proteins using Western analysis with specific ER␣ or ER␤ antibodies.
The reason for the apparent absence of estrogen and other steroid receptors is probably due to the nature of the GnRH neuron itself and/or to limitations in the sensitivity of detection methods used at the time. GnRH neurons are rare and dispersed in the hypothalamus. Furthermore, it is possible that only subgroups of GnRH neurons contain steroid receptors, as noted with progestin receptors (35) . Thus, classical approaches may not have been sensitive enough to detect very low levels of receptors within GnRH neurons. Furthermore, the reproductive status of the animal, ovariectomized or at various stages of the estrous cycle, may change the steroid responsiveness of the GnRH neuron. The sex steroid environment of the GnRH neuron may dictate the level of ER expressed, as autoregulation of ER gene expression is common (36 -38) . Similarly, there has been some variability in the detection of steroid receptor expression in the GT1-7 cell line, which may also be due to the steroid environment of the cells. Receptor mRNA levels may depend upon the type of serum used or the length of time the cells have been growing in the medium before cDNA preparation.
The in vivo studies examining the effects of estrogen on hypothalamic GnRH mRNA levels have mostly been performed in the female rat and have unfortunately led to a great deal of controversy. The GnRH transcript levels have been analyzed in relation to the estrous cycle, ovariectomy, and estrogen replacement (3, 39) . The controversy regarding either stimulatory or down-regulatory effects of estrogen appear to result from the time of day the samples were taken and the precise location of the brain in which GnRH transcript levels were measured (40, 41) . Peterson et al. were also able to demonstrate that estrogen-induced increases in GnRH mRNA were due not only to increased gene transcription, but also to increased mRNA stability (41) . As reviewed by Herbison (2) , it appears that estrogen has stimulatory effects on GnRH mRNA expression in only rostral preoptic neurons and that a gradual increase in GnRH mRNA content, from the low levels found in the morning in estrogen-treated rats, results in a peak of expression in the early afternoon, before the onset of the LH surge. The measurement of estrogen effects on GnRH mRNA synthesis in estrogen-treated rats that were killed in the morning, a time
FIG. 5. Effects of estradiol on both
GnRH and SV40 TAg steady state mRNA levels. GT1-7 cells were treated with 1 nM estradiol or vehicle alone over a 48-h time course. Total RNA was extracted, and each sample was subjected to Northern blot analysis. Blots were probed sequentially with rat GnRH cDNA, SV40 TAg cDNA, and mouse GAPDH cDNA to monitor for variations in gel loading and transfer efficiency. Data shown are relative mRNA levels and are expressed as the mean Ϯ SEM [n ϭ 9 (GnRH) or n ϭ 3 (TAg) independent experiments]. **, P Ͻ 0.005 vs. corresponding vehicle controls. There were no significant differences between GnRH and TAg mRNA levels.
when estrogen exerts an inhibitory influence on LH secretion, is probably responsible for the inhibitory effects on GnRH mRNA levels reported (42, 43) . Therefore, the current consensus appears to be that estrogen at low levels inhibits GnRH mRNA expression relative to that in ovariectomized rats, whereas higher concentrations, in association with a circadian rhythm, enhance GnRH mRNA levels (2). Nevertheless, it is difficult to dissect the direct vs. indirect action of estrogen from in vivo studies. After exposing GT1-7 cells to a low dose of 17␤-estradiol over 48 h, we found a significant repression of GnRH mRNA levels. This effect on GnRH mRNA synthesis was mimicked by the ER␣ agonist/ER␤ antagonist HPTE, thus suggesting that ER␣ is involved in the regulation of GnRH synthesis by estradiol in GT1-7 cells.
It has recently been demonstrated that ER␣ and ER␤ may form heterodimers that bind to DNA with an affinity similar to that of ER␣ homodimers and greater than that of ER␤ homodimers (44, 45) . Heterodimers have been shown to be capable of binding to steroid receptor coactivator-1 when bound to DNA and can stimulate transcription of a reporter gene in transfected cells (46) . This indicates that ER␣ and ER␤ may cooperate in regulating estrogen-responsive gene expression in cells expressing both ERs. We have demonstrated that the GT1-7 neurons express both subtypes of the ER. Our results showing HPTE repression of GnRH mRNA levels indicate that ER␣ is involved in the regulation of GnRH by estradiol, but we cannot yet exclude the possibility that the two subtypes of ER form a heterodimer complex to achieve the observed repression of GnRH mRNA levels.
Several reports have shown that the activity of the 5Ј-regulatory region of the GnRH gene is sensitive to steroid hormone-mediated regulation. Using transient transfection experiments in human placental cells, a stimulatory ERE has been localized to the 5Ј-flanking region of the human GnRH gene (47) . Examination of the rat GnRH promoter transiently transfected into JEG-3 placental cells has identified regions other than canonical EREs important for negative transcriptional regulation of the rat GnRH gene by estrogen (48) . To date, only one study has reported estrogen-mediated negative regulation of rat GnRH promoter activity in GT1 cells (49) . Because no ER mRNA expression was detected by RT-PCR in that study, cotransfection of an ER␣ expression vector was necessary to analyze the region responsible for negative regulation of GnRH reporter constructs by estrogen. The estrogen-responsive region was found to lie between Ϫ171 and Ϫ126; however, direct binding of the ER to the DNA was not detected (49) . Although there is in vivo evidence of progestin receptor expression in GnRH neurons (35) , progesterone receptors have only been reported in GT1 cells in a preliminary study (34) . Despite this, the direct binding of progesterone receptor to nonconsensus DNA sequences of the rat GnRH promoter has been shown to repress rat GnRH gene transcription in GT1 cells in the presence of progesterone (50) . These studies set a precedent for a nonclassical steroid hormone mode of action in the GT1 neurons.
It is not clearly understood how estrogen represses GnRH mRNA expression. The regulation of GnRH synthesis by estrogen in GnRH neurons may occur at a variety of levels including the transcriptional level, through changes in RNA stability, or a combination of both. It has been established previously by transient transfection experiments that rat (48) and human (47) GnRH promoter activities are sensitive to estrogen-mediated regulation. Both of these studies relied on the transfection of ER␣ into the cells, thereby overlooking any potential effect of ER␤ on the negative regulation of GnRH. We have examined whether the steroid effects of estrogen on GnRH are exerted directly at the level of the rat GnRH gene itself by measuring the expression levels of TAg mRNA after estradiol treatment in GT1 cells. The GT1 cells were produced using the coding region of the TAg oncogene, under the control of 2.3 kb of the rat GnRH 5Ј-regulatory region. We observed down-regulation of TAg mRNA levels in a pattern that mimicked GnRH mRNA down-regulation by estradiol. This result suggests that estrogen mediates its control of the GnRH gene at the transcriptional level in a region that is located within the 2.3-kb rat GnRH 5Ј-regulatory sequence used to create the GT1-7 cell line. The 2.3-kb fragment encompasses DNA from Ϫ2987 to Ϫ1172 and Ϫ441 to ϩ104 of the rat GnRH 5Ј-regulatory region (12) . Although this region of the rat GnRH gene appears to lack the canonical ERE consensus sequence, it is entirely possible that estrogen mediates its transcriptional regulation of GnRH mRNA through either ER homo-or heterodimers that bind to a unique ERE sequence or through an indirect mechanism via protein-protein interactions.
Our study suggests that hypothalamic GnRH neurons may have the capacity to be directly regulated by estrogen. Using the hypothalamic-derived neuronal cell line, GT1-7, we have shown that steady state GnRH mRNA levels are significantly down-regulated upon treatment with estradiol, through an ER-mediated mechanism. The environmental estrogen HPTE mimics the repression of GnRH gene expression by estradiol, which implies that ER␣ is involved in this effect. However, one must also consider that the GT1-7 cell line represents a single population of neurons outside of its natural environment and cell contacts, and thus may not respond to estrogen in the same manner as a GnRH neuron in situ. Nevertheless, we have found that ERs of both subtypes are expressed within GT1-7 cells. Furthermore, our data indicate that stimulation of the GT1-7 neuron by estrogen is ultimately realized at the level of the GnRH 5Ј-regulatory region. Taken together, these results suggest that estrogen could very well contribute directly to the physiology of the GnRH neuron and that further investigation of direct effects of estrogen on GnRH neuronal function in vivo is warranted.
